-
公开(公告)号:US20230390567A1
公开(公告)日:2023-12-07
申请号:US18234686
申请日:2023-08-16
Applicant: ZOLL Medical Corporation
Inventor: Tsuyoshi Masuda , Gary A. Freeman , Kent Volosin
IPC: A61N1/39 , A61B5/024 , A61B5/00 , A61N1/04 , A61B5/0245 , A61B5/259 , A61B5/282 , A61B5/333 , A61B5/341 , A61B5/364
CPC classification number: A61N1/3904 , A61B5/02438 , A61B5/0006 , A61N1/3993 , A61N1/3987 , A61N1/046 , A61B5/0245 , A61B5/259 , A61B5/282 , A61B5/333 , A61B5/341 , A61B5/364 , A61B2562/04 , A61B2562/221 , A61B2562/0204 , A61B2562/0209
Abstract: A wearable medical device is provided for monitoring a cardiac condition of a patient, where the device is releasably mounted to the patient's chest and includes at least two skin-facing electrodes forming a first one or more ECG leads for ongoing monitoring of heart functioning and at least one touch electrode for intermittently obtaining additional circuit vectors for deriving additional metrics regarding the functioning of the patient's heart. Each touch electrode is configured to form an additional lead/vector that is a larger vector and/or separated by at least 15° from a corresponding first lead/vector formed from the first one or more ECG leads in a vector cardiogram representation of the first one or more ECG leads and the additional lead/vector.
-
公开(公告)号:US11786744B2
公开(公告)日:2023-10-17
申请号:US15923812
申请日:2018-03-16
Applicant: ZOLL Medical Corporation
Inventor: Tsuyoshi Masuda , Gary A. Freeman , Kent Volosin
IPC: A61B5/00 , A61B5/24 , A61N1/39 , A61B5/024 , A61N1/04 , A61B5/0245 , A61B5/259 , A61B5/282 , A61B5/333 , A61B5/341 , A61B5/364
CPC classification number: A61N1/3904 , A61B5/0006 , A61B5/0245 , A61B5/02438 , A61B5/259 , A61B5/282 , A61B5/333 , A61B5/341 , A61B5/364 , A61N1/046 , A61N1/3987 , A61N1/3993 , A61B2562/0204 , A61B2562/0209 , A61B2562/04 , A61B2562/221
Abstract: A wearable medical device is provided for monitoring a cardiac condition of a patient, where the device is releasably mounted to the patient's chest and includes at least two skin-facing electrodes forming a first one or more ECG leads for ongoing monitoring of heart functioning and at least one touch electrode for intermittently obtaining additional circuit vectors for deriving additional metrics regarding the functioning of the patient's heart. Each touch electrode is configured to form an additional lead/vector that is a larger vector and/or separated by at least 15° from a corresponding first lead/vector formed from the first one or more ECG leads in a vector cardiogram representation of the first one or more ECG leads and the additional lead/vector.
-
13.
公开(公告)号:US11763449B2
公开(公告)日:2023-09-19
申请号:US16938244
申请日:2020-07-24
Applicant: Zoll Medical Corporation
Inventor: Tsuyoshi Masuda , Kent Volosin
IPC: A61B5/00 , G06T7/00 , A61B5/282 , A61B5/352 , A61B5/316 , G06T5/00 , A61B7/00 , A61N1/39 , A61B5/361 , A61B5/363 , A61B7/04
CPC classification number: G06T7/0012 , A61B5/0006 , A61B5/282 , A61B5/316 , A61B5/352 , A61B5/4842 , A61B5/7264 , A61B7/00 , G06T5/002 , A61B5/361 , A61B5/363 , A61B7/04 , A61B2562/0219 , A61N1/3904 , G06T2207/20081 , G06T2207/30048
Abstract: Systems and methods are provided for monitoring progression of a cardiac disease in a patient by providing cardio-vibrational image matrixes and/or ECG image matrices generated using sensor data supplied by a medical device. In some examples, cardio-vibrational image matrices and/or ECG image matrices are output as image files. In some implementations, systems and methods are provided for using such cardio-vibrational image matrices and/or an ECG image matrices, and/or other clinical information, using machine learning classifiers, to assess cardiac risk in a patient. In some implementations, systems and methods are provided for using cardio-vibrational image matrixes and/or ECG image matrices, and/or other clinical information for real-time analysis of cardiac risk.
-
公开(公告)号:US20220080214A1
公开(公告)日:2022-03-17
申请号:US17456252
申请日:2021-11-23
Applicant: ZOLL Medical Corporation
Inventor: Kent Volosin
Abstract: Systems, devices, and techniques that enable medical devices to integrate and interoperate with one another are provided. In some examples, a wearable cardiac defibrillator (WCD) advantageously interoperates with an implanted pacemaker to provide a variety of benefits. For instance, in some examples, the WCD oversees execution of an antitachycardia (ATP) protocol by the implanted pacemaker and intervenes as needed. In other examples, the WCD drives an ATP protocol in which internal pacing pulses are provided by the implanted pacemaker under the control of the WCD. In other examples, the WCD monitors the activity of the implanted pacemaker to identify potential maintenance issues affecting the implanted pacemaker. The WCD and the implanted pacemaker may also interoperate to classify and act upon particular arrhythmia conditions.
-
公开(公告)号:US20190282823A1
公开(公告)日:2019-09-19
申请号:US15924969
申请日:2018-03-19
Applicant: ZOLL Medical Corporation
Inventor: Gary A. Freeman , Weilun Quan , Christopher Luke Kaufman , Kent Volosin
IPC: A61N1/39
Abstract: A medical device that includes a power source, a therapy delivery interface, therapy electrodes, electrocardiogram (ECG) sensing electrodes to sense ECG signal of a heart of a patient, a sensor interface to receive and digitize the ECG signal, and a processor. The processor is configured to analyze the ECG signal to determine a cardiac rhythm and a transform value representing a magnitude of a frequency component of the cardiac rhythm, analyze the cardiac rhythm and the transform value to detect a shockable cardiac arrhythmia by classifying the cardiac rhythm as a noise rhythm or a shockable cardiac arrhythmia rhythm based on the transform value, and causing the processor to detect the cardiac arrhythmia if classifying the cardiac rhythm as a shockable cardiac arrhythmia rhythm, initiate a treatment alarm sequence, adjust the shock delivery parameter for a defibrillation shock, and provide the defibrillation shock via the therapy electrodes.
-
公开(公告)号:US20190282821A1
公开(公告)日:2019-09-19
申请号:US15923812
申请日:2018-03-16
Applicant: Zoll Medical Corporation
Inventor: Tsuyoshi Masuda , Gary A. Freeman , Kent Volosin
IPC: A61N1/39 , A61B5/0245 , A61B5/024 , A61B5/0468 , A61B5/00 , A61B5/04 , A61B5/0408 , A61B5/0432 , A61N1/04
Abstract: A wearable medical device is provided for monitoring a cardiac condition of a patient, where the device is releasably mounted to the patient's chest and includes at least two skin-facing electrodes forming a first one or more ECG leads for ongoing monitoring of heart functioning and at least one touch electrode for intermittently obtaining additional circuit vectors for deriving additional metrics regarding the functioning of the patient's heart. Each touch electrode is configured to form an additional lead/vector that is a larger vector and/or separated by at least 15° from a corresponding first lead/vector formed from the first one or more ECG leads in a vector cardiogram representation of the first one or more ECG leads and the additional lead/vector.
-
17.
公开(公告)号:US12213812B2
公开(公告)日:2025-02-04
申请号:US18494359
申请日:2023-10-25
Applicant: ZOLL Medical Corporation
Inventor: Kent Volosin , Gary A. Freeman
Abstract: A patient monitoring device includes an ECG sensor coupled to a patient, a sensor coupled to the patient and configured to detect bio-vibrational signals, and a radiofrequency monitoring device configured to produce information responsive to electromagnetic energy reflected from the patient's thoracic cavity. A processor processes the ECG signals, the bio-vibrational signals, and the radio frequency information to generate a plurality of physiological parameters of the patient. The processor also performs at least one of a predictive analysis and a trend analysis of the plurality of physiological parameters to determine a current clinical condition of the patient. The trend analysis includes determining a substantial relationship between changes in the plurality of physiological parameters. The processor can also compare the current clinical condition of the patient to predetermined clinically actionable criteria to determine one or more clinically actionable events and provide an output relating to one or more clinically actionable events.
-
18.
公开(公告)号:US20240257939A1
公开(公告)日:2024-08-01
申请号:US18426746
申请日:2024-01-30
Applicant: ZOLL Medical Corporation
Inventor: Kent Volosin , Jason T Whiting , Rachel H Carlson
IPC: G16H20/30 , A61B5/00 , A61B5/0205 , A61B5/024 , A61B5/11 , A61B5/339 , A61B5/349 , A63B24/00 , G16H10/60 , G16H15/00 , G16H40/67 , G16H50/70
CPC classification number: G16H20/30 , A61B5/0006 , A61B5/0205 , A61B5/349 , A61B5/7475 , A63B24/0062 , G16H10/60 , G16H15/00 , G16H40/67 , G16H50/70 , A61B5/02405 , A61B5/02438 , A61B5/112 , A61B5/339 , A61B2505/09
Abstract: A system for managing an individualized cardiac rehabilitation plan for an ambulatory cardiac rehabilitation patient includes an externally worn device configured to monitor cardiac activity of the patient and a server in communication with the externally worn device. The server includes a computer-readable medium and at least one server processor configured to receive one or more inputs from a healthcare provider, develop a patient-specific cardiac rehabilitation plan, including a plurality of exercise sessions, based on the one or more inputs, transmit the rehabilitation plan to the externally worn device, receive patient data from the externally worn device, and record one or more status identifiers for each past exercise session based on the received patient data. The at least one server processor is configured to adjust the rehabilitation plan based on the one or more recorded status identifiers and transmit the adjusted rehabilitation plan to the externally worn device.
-
公开(公告)号:US11633614B2
公开(公告)日:2023-04-25
申请号:US16417688
申请日:2019-05-21
Applicant: ZOLL Medical Corporation
Inventor: Kent Volosin , Ramu Perumal
Abstract: A patient-worn ambulatory cardiac monitoring device for monitoring a patient during a patient activity includes at least one physiological sensor configured to detect signals indicative of cardiac activity, an activity sensor and associated circuitry configured to monitor patient movements, and a vibrational sensor configured to monitor a cardio-vibrational signal of the patient. The at least one physiological sensor can include one of an ECG sensor and a heart rate sensor. At least one processor in communication with the at least one physiological sensor, the activity sensor, and the vibrational sensor, is configured to measure, during the patient activity, at least one time interval between an ECG fiducial point in an ECG signal and a cardio-vibrational fiducial point in the cardio-vibrational signal during a cardiac cycle of the patient's heart.
-
公开(公告)号:US11331509B2
公开(公告)日:2022-05-17
申请号:US16891750
申请日:2020-06-03
Applicant: ZOLL Medical Corporation
Inventor: Gary A. Freeman , Weilun Quan , Christopher Luke Kaufman , Kent Volosin
Abstract: A medical device that includes a power source, a therapy delivery interface, therapy electrodes, electrocardiogram (ECG) sensing electrodes to sense ECG signal of a heart of a patient, a sensor interface to receive and digitize the ECG signal, and a processor. The processor is configured to analyze the ECG signal to determine a cardiac rhythm and a transform value representing a magnitude of a frequency component of the cardiac rhythm, analyze the cardiac rhythm and the transform value to detect a shockable cardiac arrhythmia by classifying the cardiac rhythm as a noise rhythm or a shockable cardiac arrhythmia rhythm based on the transform value, and causing the processor to detect the cardiac arrhythmia if classifying the cardiac rhythm as a shockable cardiac arrhythmia rhythm, initiate a treatment alarm sequence, adjust the shock delivery parameter for a defibrillation shock, and provide the defibrillation shock via the therapy electrodes.
-
-
-
-
-
-
-
-
-